Macrogenics (MGNX) Enterprise Value (2016 - 2025)
Macrogenics (MGNX) has disclosed Enterprise Value for 14 consecutive years, with -$57.2 million as the latest value for Q4 2025.
- On a quarterly basis, Enterprise Value rose 68.71% to -$57.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$57.2 million, a 68.71% increase, with the full-year FY2025 number at -$57.2 million, up 68.71% from a year prior.
- Enterprise Value was -$57.2 million for Q4 2025 at Macrogenics, up from -$80.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$21.5 million in Q2 2022 to a low of -$224.3 million in Q1 2023.
- A 5-year average of -$122.4 million and a median of -$108.8 million in 2022 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: skyrocketed 88.64% in 2022, then crashed 406.58% in 2023.
- Macrogenics' Enterprise Value stood at -$123.5 million in 2021, then grew by 11.81% to -$108.9 million in 2022, then increased by 7.28% to -$101.0 million in 2023, then plummeted by 81.11% to -$182.8 million in 2024, then soared by 68.71% to -$57.2 million in 2025.
- Per Business Quant, the three most recent readings for MGNX's Enterprise Value are -$57.2 million (Q4 2025), -$80.1 million (Q3 2025), and -$130.7 million (Q2 2025).